Guardant Health (GH)Director sold ~$4.2K

~$4.2K

Approx. value · 100 sh @ $41.66

7,746

Holds after · shares reported

Traded

Jun 2, 2025

Filed

Jun 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 17, 2025InsiderDirector sold ~$5.2K of GH shares in the open market
2. May 1, 2025Insider · 1 personInsiders: 6 sales (~$5.2M)
3. May 2, 2025InsiderCEO sold ~$703K of GH shares in the open market
4. May 19, 2025InsiderDirector sold ~$4.6K of GH shares in the open market
5. Jun 2, 2025 · this disclosureInsiderDirector sold ~$4.2K of GH shares in the open market

What came next

1. Jun 3, 2025InsiderOfficer sold ~$186K of GH shares in the open market
2. Jun 5, 2025InsiderCEO sold ~$84K of GH shares in the open market
3. Jun 6, 2025InsiderCEO sold ~$1.99M of GH shares in the open market
4. Jun 9, 2025InsiderCEO sold ~$3.9M of GH shares in the open market
5. Jun 13, 2025InsiderDirector sold ~$158K of GH shares in the open market
6. Jun 16, 2025InsiderDirector sold ~$131K of GH shares in the open market
7. Jun 17, 2025InsiderDirector sold ~$323K of GH shares in the open market
8. Jun 18, 2025Insider · 2 peopleInsiders: 2 sales (~$160K)
9. Jul 1, 2025Insider · 1 personInsiders: 2 sales (~$5.1M)
10. Jul 17, 2025Insider · 2 peopleInsiders: 2 sales (~$7K)
11. Aug 19, 2025Insider · 2 peopleInsiders: 2 sales (~$8K)
12. Aug 21, 2025InsiderOfficer sold ~$124K of GH shares in the open market
13. Sep 2, 2025InsiderDirector sold ~$6.6K of GH shares in the open market
14. Sep 9, 2025Insider · 1 personInsiders: 2 sales (~$17.8M)
15. Sep 12, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 12, 2025, the Board of Directors (the “Board”) of Guardant Health, Inc. (the “Company”) increased the number of directors on the Board to 11 and appointed Alex M. Azar II, former United States Secretary of Health and Human Services, as a Class III director of the Company, to be effective as of September 12, 2025.”
16. Sep 12, 2025InsiderDirector sold ~$117K of GH shares in the open market
17. Sep 17, 2025Insider · 2 peopleInsiders: 2 sales (~$8K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Guardant Health

For Guardant Health, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 23 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GH page.

Other recent filings by Meghan V. Joyce, Director

• SEC Form 4 at Guardant Health (GH)Sep 3, 2025
• SEC Form 4 at Guardant Health (GH)Jun 16, 2025
• SEC Form 4 at Guardant Health (GH)Mar 5, 2025
• SEC Form 4 at Guardant Health (GH)Dec 4, 2024
• SEC Form 4 at Guardant Health (GH)Nov 14, 2024

The full history of Meghan V. Joyce, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Guardant Health

• SEC Form 4Oct 19, 2026
• SEC Form 144Oct 16, 2026
• SEC Form 4Oct 15, 2026
• SEC Form 144Oct 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its GH page.